These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 15735658

  • 1. Mechanisms of inverse agonist action at D2 dopamine receptors.
    Roberts DJ, Strange PG.
    Br J Pharmacol; 2005 May; 145(1):34-42. PubMed ID: 15735658
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Co-operativity in agonist binding at the D2 dopamine receptor: evidence from agonist dissociation kinetics.
    Kara E, Lin H, Strange PG.
    J Neurochem; 2010 Mar; 112(6):1442-53. PubMed ID: 20050980
    [Abstract] [Full Text] [Related]

  • 4. Agonist action at D2(long) dopamine receptors: ligand binding and functional assays.
    Gardner B, Strange PG.
    Br J Pharmacol; 1998 Jul; 124(5):978-84. PubMed ID: 9692784
    [Abstract] [Full Text] [Related]

  • 5. Mechanisms of agonist action at D2 dopamine receptors.
    Roberts DJ, Lin H, Strange PG.
    Mol Pharmacol; 2004 Dec; 66(6):1573-9. PubMed ID: 15340043
    [Abstract] [Full Text] [Related]

  • 6. Agonism and inverse agonism at dopamine D2-like receptors.
    Strange PG.
    Clin Exp Pharmacol Physiol Suppl; 1999 Apr; 26():S3-9. PubMed ID: 10386247
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures.
    Siehler S, Nunn C, Zupanc GK, Hoyer D.
    Auton Autacoid Pharmacol; 2005 Jan; 25(1):1-16. PubMed ID: 15659149
    [Abstract] [Full Text] [Related]

  • 11. Constitutive coupling of a chimeric dopamine D2/alpha 1B receptor to the phospholipase C pathway: inverse agonism to silent antagonism by neuroleptic drugs.
    Wurch T, Boutet-Robinet EA, Palmier C, Colpaert FC, Pauwels PJ.
    J Pharmacol Exp Ther; 2003 Jan; 304(1):380-90. PubMed ID: 12490615
    [Abstract] [Full Text] [Related]

  • 12. The dopaminergic stabilizer ASP2314/ACR16 selectively interacts with D2(High) receptors.
    Seeman P, Tokita K, Matsumoto M, Matsuo A, Sasamata M, Miyata K.
    Synapse; 2009 Oct; 63(10):930-4. PubMed ID: 19588469
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mechanisms of agonism and inverse agonism at serotonin 5-HT1A receptors.
    McLoughlin DJ, Strange PG.
    J Neurochem; 2000 Jan; 74(1):347-57. PubMed ID: 10617139
    [Abstract] [Full Text] [Related]

  • 15. Agonist action at D2(short) dopamine receptors determined in ligand binding and functional assays.
    Gardner BR, Hall DA, Strange PG.
    J Neurochem; 1997 Dec; 69(6):2589-98. PubMed ID: 9375693
    [Abstract] [Full Text] [Related]

  • 16. The influence of G protein subtype on agonist action at D2 dopamine receptors.
    Nickolls SA, Strange PG.
    Neuropharmacology; 2004 Nov; 47(6):860-72. PubMed ID: 15527820
    [Abstract] [Full Text] [Related]

  • 17. [3H] A-369508 ([2-[4-(2-cyanophenyl)-1-piperazinyl]-N-(3-methylphenyl) acetamide): an agonist radioligand selective for the dopamine D4 receptor.
    Moreland RB, Terranova MA, Chang R, Uchic ME, Matulenko MA, Surber BW, Stewart AO, Brioni JD.
    Eur J Pharmacol; 2004 Aug 23; 497(2):147-54. PubMed ID: 15306199
    [Abstract] [Full Text] [Related]

  • 18. Protean agonism at the dopamine D2 receptor: (S)-3-(3-hydroxyphenyl)-N-propylpiperidine is an agonist for activation of Go1 but an antagonist/inverse agonist for Gi1,Gi2, and Gi3.
    Lane JR, Powney B, Wise A, Rees S, Milligan G.
    Mol Pharmacol; 2007 May 23; 71(5):1349-59. PubMed ID: 17287401
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms of G protein activation via the D2 dopamine receptor: evidence for persistent receptor/G protein interaction after agonist stimulation.
    Quirk K, Roberts DJ, Strange PG.
    Br J Pharmacol; 2007 May 23; 151(1):144-52. PubMed ID: 17351658
    [Abstract] [Full Text] [Related]

  • 20. Specific binding of [(11)C]raclopride and N-[(3)H]propyl-norapomorphine to dopamine receptors in living mouse striatum: occupancy by endogenous dopamine and guanosine triphosphate-free G protein.
    Cumming P, Wong DF, Gillings N, Hilton J, Scheffel U, Gjedde A.
    J Cereb Blood Flow Metab; 2002 May 23; 22(5):596-604. PubMed ID: 11973432
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.